Natural Products with Antiplatelet Action

Gabriela Elisa Hirsch1, Paulo Ricardo Nazario Viecili1, Amanda Spring de Almeida1

  • 1Programa de Pós-Graduação em Atenção Integral à Saúde (PPGAIS), Universidade de Cruz Alta (UNICRUZ), 98020-290 Cruz Alta, RS. Brazil.

Insights

Medicinal plants like saffron and garlic can inhibit platelet aggregation, a key factor in cardiovascular diseases. These natural compounds offer potential for developing new antiplatelet drugs.

Area of Science:

  • Pharmacology
  • Cardiovascular Science
  • Phytochemistry

Background:

  • Platelet aggregation is a critical factor in cardiovascular diseases such as atherosclerosis.
  • Dysregulation of platelet activity, including aggregation and reduced blood flow, contributes to disease progression.
  • Key platelet activation pathways involve arachidonic acid, adenosine diphosphate, serotonin, nitric oxide, and free radical actions.

Purpose of the Study:

  • To review medicinal plants with antiplatelet activity.
  • To identify phytochemical components responsible for antiplatelet effects.
  • To explore the potential of these plants in complementary and alternative medicine for cardiovascular health.

Main Methods:

  • Literature review of studies on medicinal plants and their effects on platelet aggregation.
  • Identification of plants with documented antiplatelet properties.
  • Analysis of phytochemical constituents linked to antiplatelet activity.

Main Results:

  • Several medicinal plants, including saffron, garlic, green tea, St. John's wort, ginger, ginkgo biloba, ginseng, and guavirova, exhibit antiplatelet activity.
  • Phytochemicals such as flavonoids, curcumins, catechins, terpenoids, polyphenols, and saponins are associated with the observed antiplatelet effects.
  • These plants are found globally, with a majority originating from Asia.

Conclusions:

  • Medicinal plants and their compounds demonstrate significant antiplatelet activity.
  • These natural agents represent promising candidates for the development of novel therapeutic agents.
  • Further research into these plants could lead to new treatments for aggregation-related disorders.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.3K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.4K